AI Matrx Logo

Clinical research lab

Ostrander Ridge Clinical Research · Clinical research lab · Cincinnati, OH

Dr. Hana Petrov coordinates a phase II trial at Ostrander Ridge Clinical Research in Cincinnati, and she uses this to keep every subject's visits, consent versions and protocol deviations audit-ready, with a checklist for each step the monitor will ask about.

HealthcareComplianceChecklists5 tables · 6 views · 1 form · 2 dimension sets · 2 checklists · 1 document · 1 notification · 1 stage rule set · 1 agent
Use this template

Subject board

Subjects
Screening4
LCR-1156UTMay 6, 1973
LCR-1158KZAug 17, 1959
LCR-1165VMJan 26, 1965
LCR-1170SANov 14, 1969
Screen failed3
LCR-1173ZDJun 2, 1953
LCR-1182QEApr 19, 1976
LCR-1188XRDec 30, 1957
Enrolled5
LCR-1126PKMar 8, 1964
LCR-1131WLDec 15, 1970
LCR-1139ICJul 29, 1956
LCR-1142GRFeb 21, 1967
LCR-1146JBOct 11, 1962
In follow-up6
LCR-1095EJAug 5, 1963
LCR-1099HMMay 19, 1955
LCR-1102NGOct 27, 1968
LCR-1109FQJan 12, 1960
LCR-1118YSApr 4, 1971
1 more
Completed5
LCR-1047MOApr 22, 1961
LCR-1051DKNov 3, 1957
LCR-1060RPJul 18, 1969
LCR-1063LHFeb 27, 1954
LCR-1069TSSep 9, 1972
Withdrawn3
LCR-1077ANJun 14, 1966
LCR-1079CVDec 1, 1959
LCR-1084BWMar 30, 1974

Tables

Subjects

26 sample rows · 16 columns

Every person screened or enrolled in the trial: where they stand, which consent they signed and what is owed to them.

Subject numberInitialsDate of birthContact phoneContact emailStatusScreened
LCR-1047MOApr 22, 1961(513) 555-0102mo307.participant@ostranderparticipants.netCompletedSep 13, 2025
LCR-1051DKNov 3, 1957(513) 555-0104dk314.participant@ostranderparticipants.netCompletedSep 21, 2025
LCR-1060RPJul 18, 1969(513) 555-0106rp321.participant@ostranderparticipants.netCompletedOct 11, 2025
LCR-1063LHFeb 27, 1954(513) 555-0108lh328.participant@ostranderparticipants.netCompletedNov 7, 2025
LCR-1069TSSep 9, 1972(513) 555-0110ts335.participant@ostranderparticipants.netCompletedNov 20, 2025
LCR-1077ANJun 14, 1966(513) 555-0112an342.participant@ostranderparticipants.netWithdrawnDec 10, 2025
LCR-1079CVDec 1, 1959(513) 555-0114cv349.participant@ostranderparticipants.netWithdrawnFeb 10, 2026
LCR-1084BWMar 30, 1974(513) 555-0116bw356.participant@ostranderparticipants.netWithdrawnMar 27, 2026
LCR-1095EJAug 5, 1963(513) 555-0118ej363.participant@ostranderparticipants.netIn follow-upJun 14, 2026
LCR-1099HMMay 19, 1955(513) 555-0120hm370.participant@ostranderparticipants.netIn follow-upJun 20, 2026
LCR-1102NGOct 27, 1968(513) 555-0122ng377.participant@ostranderparticipants.netIn follow-upJun 26, 2026
LCR-1109FQJan 12, 1960(513) 555-0124fq384.participant@ostranderparticipants.netIn follow-upJul 2, 2026

14 more rows

Visits

49 sample rows · 9 columns

Each study visit: which subject, what kind, when it was booked, whether it happened and the stipend that follows.

VisitVisit numberSubjectVisit typeStatusScheduled forCompleted on
LCR-1146 BaselineV-2137LCR-1146BaselineCompletedOct 4, 2026Oct 4, 2026
LCR-1156 ScreeningV-2139LCR-1156ScreeningCompletedOct 6, 2026Oct 6, 2026
LCR-1109 End of treatmentV-2123LCR-1109End of treatmentCompletedOct 8, 2026Oct 8, 2026
LCR-1131 Week 4V-2131LCR-1131Week 4CompletedOct 8, 2026Oct 8, 2026
LCR-1158 ScreeningV-2141LCR-1158ScreeningCompletedOct 9, 2026Oct 9, 2026
LCR-1142 Week 2V-2135LCR-1142Week 2CompletedOct 11, 2026Oct 11, 2026
LCR-1165 ScreeningV-2143LCR-1165ScreeningCompletedOct 12, 2026Oct 12, 2026
LCR-1118 End of treatmentV-2125LCR-1118End of treatmentCompletedOct 13, 2026Oct 13, 2026
LCR-1170 ScreeningV-2145LCR-1170ScreeningCompletedOct 15, 2026Oct 15, 2026
LCR-1139 Week 4V-2133LCR-1139Week 4CompletedOct 16, 2026Oct 16, 2026
LCR-1120 End of treatmentV-2127LCR-1120End of treatmentCompletedOct 17, 2026Oct 17, 2026

Consent versions

3 sample rows · 5 columns

Each approved version of the consent form, when the review board approved it and when it took effect.

Consent formBoard approvedIn effect fromStatus
Consent form v3.0Jul 15, 2026Aug 4, 2026Current
Consent form v2.0Feb 10, 2026Mar 2, 2026Superseded
Consent form v1.0Aug 4, 2025Aug 24, 2025Superseded

Protocol deviations

14 sample rows · 9 columns

Every departure from the protocol, how serious it is, and whether the review board has been told.

DeviationDeviation numberSubjectCategorySeverityFound onReported on
LCR-1131: visit outside windowPD-108LCR-1131Visit outside windowMinorSep 30, 2026—
LCR-1139: dosingPD-109LCR-1139DosingMinorOct 6, 2026—
LCR-1102: missed procedurePD-110LCR-1102Missed procedureMinorOct 9, 2026—
LCR-1146: consentPD-111LCR-1146ConsentMinorOct 13, 2026—
LCR-1142: eligibilityPD-113LCR-1142EligibilityMajorOct 15, 2026—

Also included

  • Deviation reportDocumentThe one-page report the investigator signs for every deviation.
  • Enrollment readinessChecklist
  • Deviation closeoutChecklist
  • Subject stagesStage rules
  • Visit coming upNotificationReminds the coordinator two days before a subject's visit.

Related templates